DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Wednesday, 11 November 2015

Ram W. Sabnis

image


Ram W. Sabnis is a Senior Patent Agent in USA. His interests include dyes, pigments, organic chemistry, heterocycles, polymers, synthesis, formulations, coatings and patents. Presently, he focuses on drafting and prosecuting US and international patents. 

He is a registered patent agent with US Patent and Trademark Office (USPTO). Prior to entering the legal (patents) field, he was a research chemist for Ascadia, General Electric, Brewer Science, U.S. Textiles and Thermo Fisher (Molecular Probes) in USA. 

He also worked as a Patent Agent at Squire Patton Boggs L.L.P. and Senior Manager at Pfizer Inc. (Wyeth).

Dr. Sabnis was born and raised in Mumbai, India. He received his Ph.D. in Organic Chemistry (Dye Chemistry) from Institute of Chemical Technology (ICT) (formerly UDCT), Mumbai, India. 

He is a Chartered Colourists, Fellow of Society of Dyers and Colourists (CCol FSDC).

Dr. Sabnis is one of the world's foremost experts in dyes, inventing world's first colored bubbles (non-staining) and color changing dye system with many applications. 

He has immensely contributed to color science and technology for the past 25 years, particularly, dyes for biomedicine, personal care products, health/beauty products, electronics (displays, OLEDs), inks, paints, plastics, textiles and toys/bubbles.

He has over 200 publications which include books, book chapters, encyclopedia chapters, patents, reviews, papers, and symposia presentations. He is also an inventor of several US and international patents (issued/published). Dr. Sabnis is the recipient of Pfish Award, Perkin Innovation Award, Grand Innovation Award, Competitive Spirit Award and Best Doctoral Thesis Award. 

Dr. Sabnis is awarded the Gold Medal for “Outstanding service to the coloration industry” by the Society of Dyers and Colourists, Bradford, U.K.

He has written two books on color chemistry, namely, “Handbook of Biological Dyes and Stains” and “Handbook of Acid-Base Indicators.” He will continue to focus his activities on fascinating dye chemistry as well as demanding intellectual property in the years to come.






BOOK


Cover Page


For general information on our other products and services or for technical support, please contact our Customer Care Department within the United States at (800) 762-2974, outside the United States at (317) 572-3993 or fax (317) 572-4002.
Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic formats. For more information about Wiley products, visit our web site at www.wiley.com.
Library of Congress Cataloging-in-Publication Data:
Sabnis, R. W. (Ram Wasudeo)
Handbook of fluorescent dyes and probes / R.W. Sabnis.
pages cm
Includes index.
ISBN 978-1-118-02869-8 (cloth)
I express my profound respect and appreciation to my Guru/Mentor/Advisor, Prof. D. W. Rangnekar, who brought me to this wonderful world of Color Science in the Department of Dyestuffs Technology, Institute of Chemical Technology (ICT), where I laid the foundation stone for my research career in Dye Chemistry.
It is a pleasure to make grateful acknowledgement to Dr. Alan Fanta, Dr. Doina Ene, and Dr. Jeffrey Talkington for extremely useful discussions, encouragement and inspiration.
Words are inadequate to express my sincere appreciation to my wife Madhuri and daughter Anika. It would not have been possible to write this book without their encouragement and patience. It is a great pleasure to express my gratitude and appreciation to John Wiley & Sons Inc., for giving me an opportunity to write this book.
R. W. Sabnis
E-mail: ramsabnis@yahoo.com
http://radaris.com/p/Ram/Sabnis/




http://onlinelibrary.wiley.com/doi/10.1002/9780470586242.fmatter/pdf





PH D 
ICT, MUMBAI,
DR D W RANGNEKAR
DYES SECTION
Image result for ict mumbai




Ram W. Sabnis

Trisubstituted methyl alcohols and their polymerizable derivatives

Patent number: 9115066
Abstract: Provided herein are trisubstituted methyl alcohols, preferably pH indicators that are substituted with optionally substituted aryl and or optionally substituted heteroaryl groups, and optionally include one or more polymerizable substituents.
Type: Grant
Filed: December 14, 2012
Issued: August 25, 2015
Assignee: Indicator Systems International, Inc.
Inventors: Gerald F. Swiss, Photon Rao, Ram W. Sabnis

INFECTION INDICATING MEDICAL DEVICES

Application number: 20150037258
Abstract: Provided herein is an implantable medical device capable of self-reporting microbial growth adjacent the site of the implanted device.
Type: Application
Filed: June 23, 2014
Issued: February 5, 2015
Inventors: Gerald F. Swiss, Robert M. Moriarty, Ram W. Sabnis

Indicators for detecting the presence of metabolic byproducts from microorganisms

Patent number: 8425996
Abstract: Polymeric indicator films and pH indicating wraps are provided for visually monitoring, detecting, and/or determining the presence of metabolic byproducts from harmful or potentially harmful microorganisms. Also provided are methods of use and preparation of the polymeric indicator films.
Type: Grant
Filed: January 25, 2010
Issued: April 23, 2013
Assignee: Indicator Systems International, Inc.
Inventors: Joel R. Gorski, Jon Booher, Ram W. Sabnis

INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BY-PRODUCTS FROM MICROORGANISMS

Application number: 20120316408
Abstract: pH indicator compositions, solutions and suspensions and pH indicating food storage devices, medical devices and components thereof are provided for visually monitoring, detecting, and/or determining the presence of metabolic by-products from harmful or potentially harmful microorganisms. Also provided are methods of use and preparation of the pH indicator compositions, solutions and suspensions.
Type: Application
Filed: May 10, 2012
Issued: December 13, 2012
Inventors: Joel R. Gorski, Ram W. Sabnis

COMPOSITION AND METHOD FOR PRODUCING COLORED BUBBLES

Application number: 20120244777
Abstract: Compositions and methods for producing substantially uniformly colored bubbles are described. The composition comprises at least one surfactant mixed with at least one colorant, the colorant forming at least approximately 10% of the composition. The surfactant, or surface-active agent, forms the bubble while the colorant, or pigment, provides the color. Generally, the composition may comprise 10-99% colorant to produce varying degrees of opacity. In addition, glycerin, fragrance, propylene glycol, sodium lauryl sulfate, potassium hydroxide, or other additives may be included.
Type: Application
Filed: March 22, 2011
Issued: September 27, 2012
Inventors: Ram W. Sabnis, Timothy D. Kehoe

Composition and method for producing colored bubbles

Patent number: 7910531
Abstract: Compositions and methods for producing colored bubbles, having a single color uniformly dispersed in the film, are described. The composition comprises at least one surfactant mixed with at least one colorant, the colorant forming at least approximately 10% of the composition. The surfactant, or surface-active agent, forms the bubble while the colorant, or pigment, provides the color. Generally, the composition may comprise 10-99% colorant to produce varying degrees of opacity. In addition, glycerin, fragrance, propylene glycol, sodium lauryl sulfate, potassium hydroxide, or other additives may be included.
Type: Grant
Filed: June 13, 2005
Issued: March 22, 2011
Assignee: C2C Technologies LLC
Inventors: Ram W. Sabnis, Timothy D. Kehoe

INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS

Application number: 20100196636
Abstract: Polymeric indicator films and pH indicating wraps are provided for visually monitoring, detecting, and/or determining the presence of metabolic byproducts from harmful or potentially harmful microorganisms. Also provided are methods of use and preparation of the polymeric indicator films.
Type: Application
Filed: January 25, 2010
Issued: August 5, 2010
Inventors: Joel R. Gorski, Jon Booher, Ram W. Sabnis

Lithography pattern shrink process and articles

Patent number: 7449230
Abstract: Novel processes of applying a thin, uniform, conformal organic polymeric film by a wide variety of deposition processes into lithography pattern substrates are provided. The inventive processes result in shrinking of the gaps in the lithography pattern equally, thus producing a smaller dimension. The amount of pattern shrinkage is selectively controlled by controlling the deposition rate to provide the desired final structure dimension. A wide variety of organic films is used as materials for these films. The inventive methods are applicable to any patterning technique used in lithography to provide a reduction in pattern sizes. Examples of the applicable device levels include the production of gate layers, ion implantation of active device layers and substantive metal layers, dielectric patterning, interconnect processes produced by damascene, dual damascene, backend packaging layers, and devices requiring multiple layers deposited by electrodeposition, CVD or sputtering.
Type: Grant
Filed: February 23, 2005
Issued: November 11, 2008
Assignee: Brewer Science Inc.
Inventors: Ram W. Sabnis, James E. Lamb, III

Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition

Patent number: 7132219
Abstract: An improved method for applying polymeric antireflective coatings to substrate surfaces and the resulting precursor structures are provided. Broadly, the methods comprise plasma enhanced chemical vapor depositing (PECVD) a polymer on the substrate surfaces. The most preferred starting monomers are 4-fluorostyrene, 2,3,4,5,6-pentafluorostyrene, and allylpentafluorobenzene. The PECVD processes comprise subjecting the monomers to sufficient electric current and pressure so as to cause the monomers to sublime to form a vapor which is then changed to the plasma state by application of an electric current. The vaporized monomers are subsequently polymerized onto a substrate surface in a deposition chamber. The inventive methods are useful for providing highly conformal antireflective coatings on large surface substrates having super submicron (0.25 ?m or smaller) features.
Type: Grant
Filed: April 9, 2003
Issued: November 7, 2006
Assignee: Brewer Science Inc.
Inventors: Ram W. Sabnis, Wu-Sheng Shih, Douglas J. Guerrero

Lithography pattern shrink process and articles

Patent number: 7122296
Abstract: Novel processes of applying a thin, uniform, conformal organic polymeric film by a wide variety of deposition processes into lithography pattern substrates are provided. The inventive processes result in shrinking of the gaps in the lithography pattern equally, thus producing a smaller dimension. The amount of pattern shrinkage is selectively controlled by controlling the deposition rate to provide the desired final structure dimension. A wide variety of organic films is used as materials for these films. The inventive methods are applicable to any patterning technique used in lithography to provide a reduction in pattern sizes. Examples of the applicable device levels include the production of gate layers, ion implantation of active device layers and substantive metal layers, dielectric patterning, interconnect processes produced by damascene, dual damascene, backend packaging layers, and devices requiring multiple layers deposited by electrodeposition, CVD or sputtering.
Type: Grant
Filed: March 3, 2003
Issued: October 17, 2006
Assignee: Brewer Science Inc.
Inventors: Ram W. Sabnis, James E. Lamb, III

Organic polymeric antireflective coatings deposited by chemical vapor deposition

Patent number: 6936405
Abstract: An improved method for applying organic antireflective coatings to substrate surfaces and the resulting precursor structures are provided. Broadly, the methods comprise chemical vapor depositing (CVD) an antireflective compound on the substrate surface. In one embodiment, the compound is highly strained (e.g., having a strain energy of at least about 10 kcal/mol) and comprises two cyclic moieties joined to one another via a linkage group. The most preferred monomers are [2.2](1,4)-naphthalenophane and [2.2](9,10)-anthracenophane. The CVD processes comprise heating the antireflective compound so as to vaporize it, and then pyrolizing the vaporized compound to form stable diradicals which are subsequently polymerized on a substrate surface in a deposition chamber. The inventive methods are useful for providing highly conformal antireflective coatings on large substrate surfaces having super submicron (0.25 ?m or smaller) features.
Type: Grant
Filed: December 21, 2000
Issued: August 30, 2005
Assignee: Brewer Science Inc.
Inventors: Ram W. Sabnis, Douglas J. Guerrero, Terry Brewer, Mary J. Spencer

Organic polymeric antireflective coatings deposited by chemical vapor deposition

Patent number: 6900000
Abstract: An improved method for applying organic antireflective coatings to substrate surfaces and the resulting precursor structures are provided. Broadly, the methods comprise chemical vapor depositing (CVD) an antireflective compound on the substrate surface. In one embodiment, the compound is highly strained (e.g., having a strain energy of at least about 10 kcal/mol) and comprises two cyclic moieties joined to one another via a linkage group. The most preferred monomers are [2.2](1,4)-naphthalenophane and [2.2](9,10)-anthracenophane. The CVD processes comprise heating the antireflective compound so as to vaporize it, and then pyrolizing the vaporized compound to form stable diradicals which are subsequently polymerized on a substrate surface in a deposition chamber. The inventive methods are useful for providing highly conformal antireflective coatings on large substrate surfaces having super submicron (0.25 ?m or smaller) features.
Type: Grant
Filed: June 28, 2002
Issued: May 31, 2005
Assignee: Brewer Science Inc.
Inventors: Ram W. Sabnis, Douglas J. Guerrero, Terry Brewer, Mary J. Spencer

Organic polymeric antireflective coatings deposited by chemical vapor deposition

Patent number: 6869747
Abstract: An improved method for applying organic antireflective coatings to substrate surfaces and the resulting precursor structures are provided. Broadly, the methods comprise chemical vapor depositing (CVD) an antireflective compound on the substrate surface. In one embodiment, the compound is highly strained (e.g., having a strain energy of at least about 10 kcal/mol) and comprises two cyclic moieties joined to one another via a linkage group. The most preferred monomers are [2.2](1,4)-naphthalenophane and [2.2](9,10)-anthracenophane. The CVD processes comprise heating the antireflective compound so as to vaporize it, and then pyrolizing the vaporized compound to form stable diradicals which are subsequently polymerized on a substrate surface in a deposition chamber. The inventive methods are useful for providing highly conformal antireflective coatings on large substrate surfaces having super submicron (0.25 ?m or smaller) features.
Type: Grant
Filed: June 28, 2002
Issued: March 22, 2005
Assignee: Brewer Science Inc.
Inventors: Ram W. Sabnis, Douglas J. Guerrero, Terry Brewer, Mary J. Spencer

Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition

Patent number: 6852474
Abstract: An improved method for applying polymeric antireflective coatings to substrate surfaces and the resulting precursor structures are provided. Broadly, the methods comprise plasma enhanced chemical vapor depositing (PECVD) a polymer on the substrate surfaces. The PECVD processes comprise providing a quantity of a polymer generated by introducing monomer vapors into a plasma state followed by polymerization thereof, with assistance of plasma energy, onto the surface of a substrate. The most preferred starting monomers are phenylacetylene, 4-ethynyltoluene, and 1-ethynyl-2-fluorobenzene. The inventive methods are useful for providing highly conformal antireflective coatings on large surface substrates having super submicron (0.25 ?m or smaller) features. The process provides a much faster deposition rate than conventional chemical vapor deposition (CVD) methods, is environmentally friendly, and is economical.
Type: Grant
Filed: April 24, 2003
Issued: February 8, 2005
Assignee: Brewer Science Inc.
Inventor: Ram W. Sabnis

Photosensitive black matrix

Application number: 20040048197
Abstract: A spin coatable, photosensitive black matrix coating having high surface resistivity and exhibiting an optical density greater than 3 at film thicknesses of ≦1 micron has been developed for flat panel display applications where a chrome/chrome oxide black matrix is usually employed. It possesses excellent thermal, light, and chemical stability and good shelf life. It is deposited and patterned by a simple photolithographic processes excellent thermal, light, and chemical stability and good shelf life. It is deposited and patterned by a simple photolithographic process, thereby reducing the cost of processing in relation to chrome/chrome oxide black matrix fabrication processes.
Type: Application
Filed: September 8, 2003
Issued: March 11, 2004
Inventors: Ram W. Sabnis, Jonathan W. Mayo, Terry L. Brewer, Michael D. Stroder, Kiyomi Ema, Yasuhisa Sone, Takayasu Nihira, Kazuhiro Aoba, Akira Yanagimoto

Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition

Application number: 20030224586
Abstract: An improved method for applying polymeric antireflective coatings to substrate surfaces and the resulting precursor structures are provided. Broadly, the methods comprise plasma enhanced chemical vapor depositing (PECVD) a polymer on the substrate surfaces. The PECVD processes comprise providing a quantity of a polymer generated by introducing monomer vapors into a plasma state followed by polymerization thereof, with assistance of plasma energy, onto the surface of a substrate. The most preferred starting monomers are phenylacetylene, 4-ethynyltoluene, and 1-ethynyl-2-fluorobenzene. The inventive methods are useful for providing highly conformal antireflective coatings on large surface substrates having super submicron (0.25 &mgr;m or smaller) features. The process provides a much faster deposition rate than conventional chemical vapor deposition (CVD) methods, is environmentally friendly, and is economical.
Type: Application
Filed: April 24, 2003
Issued: December 4, 2003
Assignee: Brewer Science, Inc.
Inventor: Ram W. Sabnis

Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition

Application number: 20030219541
Abstract: An improved method for applying polymeric antireflective coatings to substrate surfaces and the resulting precursor structures are provided. Broadly, the methods comprise plasma enhanced chemical vapor depositing (PECVD) a polymer on the substrate surfaces. The most preferred starting monomers are 4-fluorostyrene, 2,3,4,5,6-pentafluorostyrene, and allylpentafluorobenzene. The PECVD processes comprise subjecting the monomers to sufficient electric current and pressure so as to cause the monomers to sublime to form a vapor which is then changed to the plasma state by application of an electric current. The vaporized monomers are subsequently polymerized onto a substrate surface in a deposition chamber. The inventive methods are useful for providing highly conformal antireflective coatings on large surface substrates having super submicron (0.25 &mgr;m or smaller) features.
Type: Application
Filed: April 9, 2003
Issued: November 27, 2003
Assignee: Brewer Science, Inc.
Inventors: Ram W. Sabnis, Wu-Sheng Shih, Douglas J. Guerrero

Lithography pattern shrink process and articles

Application number: 20030203320
Abstract: Novel processes of applying a thin, uniform, conformal organic polymeric film by a wide variety of deposition processes into lithography pattern substrates are provided. The inventive processes result in shrinking of the gaps in the lithography pattern equally, thus producing a smaller dimension. The amount of pattern shrinkage is selectively controlled by controlling the deposition rate to provide the desired final structure dimension. A wide variety of organic films is used as materials for these films. The inventive methods are applicable to any patterning technique used in lithography to provide a reduction in pattern sizes. Examples of the applicable device levels include the production of gate layers, ion implantation of active device layers and substantive metal layers, dielectric patterning, interconnect processes produced by damascene, dual damascene, backend packaging layers, and devices requiring multiple layers deposited by electrodeposition, CVD or sputtering.
Type: Application
Filed: March 3, 2003
Issued: October 30, 2003
Assignee: BREWER SCIENCE, INC.
Inventors: Ram W. Sabnis, James E. Lamb

Photosensitive black matrix

Application number: 20030113640
Abstract: A spin coatable, photosensitive black matrix coating having high surface resistivity and exhibiting an optical density greater than 3 at film thicknesses of ≦1 micron has been developed for flat panel display applications where a chrome/chrome oxide black matrix is usually employed. It possesses excellent thermal, light, and chemical stability and good shelf life. It is deposited and patterned by a simple photolithographic processes excellent thermal, light, and chemical stability and good shelf life. It is deposited and patterned by a simple photolithographic process, thereby reducing the cost of processing in relation to chrome/chrome oxide black matrix fabrication processes.
Type: Application
Filed: October 21, 2002
Issued: June 19, 2003
Inventors: Ram W. Sabnis, Jonathan W. Mayo, Terry L. Brewer, Michael D. Stroder, Kiyomi Ema, Yasuhisa Sone, Takayasu Nihira, Kazuhiro Aoba, Akira Yanagimoto

Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition

Application number: 20030064608
Abstract: An improved method for applying polymeric antireflective coatings to substrate surfaces and the resulting precursor structures are provided. Broadly, the methods comprise plasma enhanced chemical vapor depositing (PECVD) a polymer on the substrate surfaces. The most preferred starting monomers are 4-fluorostyrene, 2,3,4,5,6-pentafluorostyrene, and allylpentafluorobenzene. The PECVD processes comprise subjecting the monomers to sufficient electric current and pressure so as to cause the monomers to sublime to form a vapor which is then changed to the plasma state by application of an electric current. The vaporized monomers are subsequently polymerized onto a substrate surface in a deposition chamber. The inventive methods are useful for providing highly conformal antireflective coatings on large surface substrates having super submicron (0.25 &mgr;m or smaller) features.
Type: Application
Filed: September 24, 2002
Issued: April 3, 2003
Inventors: Ram W. Sabnis, Douglas J. Guerrero



PUBLICATIONS

US Patents

Cleansing Compositions With Color Changing Indicator
United States PatentInventorAppl. No.Assignee
#2006025Nov 16, 2006
Filed: Mar 28, 2006
Ram Sabnis (Eagan, MN)
Timothy Kehoe (St. Paul, MN)
Robert Balchunis (St. Paul, MN)		11/391004
International Classification:A61K 8/35U.S. Classification:424401000
Abstract:The invention describes compositions that can indicate whether hands have been washed for an approximate predetermined period of time. The composition includes an acid-base indicator and a delivery system.
Use Of Color Changing Indicators In Consumer Products
United States PatentInventorAppl. No.Assignee
#2007001Jan 11, 2007
Filed: Jun 23, 2006
Ram Sabnis (Eagan, MN)
Timothy Kehoe (St. Paul, MN)
Robert Balchunis (St. Paul, MN)		11/474518
International Classification:A01N 25/00U.S. Classification:504116100
Abstract:The invention describes uses of various acid-base indicators in combination with consumer products, such as herbicides, where upon application the surface treated is visualized by color and then, with time, the color disappears.
Novelty Compositions With Color Changing Indicator
United States PatentInventorAppl. No.Assignee
#2006023Oct 26, 2006
Filed: Mar 28, 2006
Ram Sabnis (Mendota Heights, MN)
Timothy Kehoe (St. Paul, MN)
Robert Balchunis (St. Paul, MN)		11/390979
International Classification:A61K 8/00U.S. Classification:008405000
Abstract:Compositions and methods for producing novel paints, bubbles, markers and cosmetics are described.
Personal Care Compositions With Color Changing Indicator
United States PatentInventorAppl. No.Assignee
#2006022Oct 5, 2006
Filed: Mar 28, 2006
Ram Sabnis (Eagan, MN)
Timothy Kehoe (St. Paul, MN)
Robert Balchunis (St. Paul, MN)		11/391725
International Classification:A01N 25/00U.S. Classification:424405000
Abstract:The invention describes a composition for use in disinfecting a surface for personal use, such as a public restroom facility or telephone. The composition and delivery of the composition provides for the placement of a thin layer of disinfectant which includes a acid-base indicator. The acid-base indicator disappears as the thin layer effects the germicidal activity of the disinfectant. The composition is also rapidly drying, so that the acid-base indicator disappears as well as the disinfecting composition leaving the surface dry. The invention also relates to use of the compositions in a lotion, such as a sunscreen. Use of the acid-base indicator provides a method to visualize where the lotion is applied by color, with the color then later dissipating.
Photosensitive Black Matrix
United States PatentInventorAppl. No.Assignee
#2004004Mar 11, 2004
Filed: Sep 8, 2003
Ram Sabnis (Rolla, MO)
Jonathan Mayo (Rolla, MO)
Terry Brewer (Rolla, MO)
Michael Stroder (Springfield, MO)
Kiyomi Ema (Chiba-shi, JP)
Yasuhisa Sone (Funabashi-shi, JP)
Takayasu Nihira (Tokyo, JP)
Kazuhiro Aoba (Narashino-shi, JP)
Akira Yanagimoto (Tokyo, JP)		10/657436
International Classification:G03C001/725U.S. Classification:430/286100, 430/281100, 430/025000, 430/028000
Abstract:A spin coatable, photosensitive black matrix coating having high surface resistivity and exhibiting an optical density greater than 3 at film thicknesses of 1 micron has been developed for flat panel display applications where a chrome/chrome oxide black matrix is usually employed. It possesses excellent thermal, light, and chemical stability and good shelf life. It is deposited and patterned by a simple photolithographic processes excellent thermal, light, and chemical stability and good shelf life. It is deposited and patterned by a simple photolithographic process, thereby reducing the cost of processing in relation to chrome/chrome oxide black matrix fabrication processes.
Oral Care Compositions With Color Changing Indicator
United States PatentInventorAppl. No.Assignee
#2006022Oct 5, 2006
Filed: Mar 28, 2006
Ram Sabnis (Eagan, MN)
Timothy Kehoe (St. Paul, MN)
Robert Balchunis (St. Paul, MN)		11/391671
International Classification:A61K 8/368, A61K 8/46U.S. Classification:424049000
Abstract:The invention describes color changing toothpastes and mouthwashes which contains acid-base indicator(s) for interaction with the oral cavity to provide a color change indicative of treatment time.
Composition And Method For Producing Colored Bubbles
United States PatentInventorAppl. No.Assignee
#2012024Sep 27, 2012
Filed: Mar 22, 2011
Ram W. Sabnis (Eagan, MN)
Timothy D. Kehoe (St. Paul, MN)		13/069012
International Classification:A63H 33/28, C09B 67/02, C09K 11/02, C09K 11/06U.S. Classification:446 15, 25230116, 25218212, 25230134
Abstract:Compositions and methods for producing substantially uniformly colored bubbles are described. The composition comprises at least one surfactant mixed with at least one colorant, the colorant forming at least approximately 10% of the composition. The surfactant, or surface-active agent, forms the bubble while the colorant, or pigment, provides the color. Generally, the composition may comprise 10-99% colorant to produce varying degrees of opacity. In addition, glycerin, fragrance, propylene glycol, sodium lauryl sulfate, potassium hydroxide, or other additives may be included.
Indicators For Detecting The Presence Of Metabolic By-Products From Microorganisms
United States PatentInventorAppl. No.Assignee
#2012031Dec 13, 2012
Filed: May 10, 2012
Joel R. Gorski (Perrysburg, OH)
Ram W. Sabnis (Roswell, GA)		13/468863
International Classification:A61B 5/00, A46B 11/00, G01N 21/80, B65D 79/00U.S. Classification:600309, 426132, 401143, 435 34
Abstract:pH indicator compositions, solutions and suspensions and pH indicating food storage devices, medical devices and components thereof are provided for visually monitoring, detecting, and/or determining the presence of metabolic by-products from harmful or potentially harmful microorganisms. Also provided are methods of use and preparation of the pH indicator compositions, solutions and suspensions.
More US Patents...
Handbook Of Acid-Base Indicators - ISBN (books and publications)
author: Ram Wasudeo Sabnis
ISBN #: 0849382181


BOOKS

Handbook of Acid-Base Indicators

https://books.google.co.in/books?isbn=084938219X
R. W. Sabnis - 2007 - ‎Preview - ‎More editions
The Handbook of Acid-Base Indicators contains practical information for widespread applications that include semiconductors, displays, nanotechnology, OLEDs, fuel cells, sensors, security, surface coatings, adhesives, insecticides, ...

Handbook of Fluorescent Dyes and Probes

https://books.google.co.in/books?isbn=1119007089
R. W. Sabnis - 2015 - ‎Preview - ‎More editions

Handbook of Biological Dyes and Stains: Synthesis and ...

https://books.google.co.in/books?isbn=0470586230
R. W. Sabnis - 2010 - ‎Preview - ‎More edit



Take a tour

 ATLANTA NORTHEAST,  USA








Lyndhurst Way, Roswell, GA 30075


Map of 1120 Lyndhurst Way, Roswell, GA 30075, USA

















 DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE


Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK
Join me on twitterFollow amcrasto on Twitter     
Join me on google plus Googleplus

 amcrasto@gmail.com

////////////



Posted by at No comments:
Labels: , , , , , , , ,

Tuesday, 10 November 2015

Hassan Y Aboul-Enein




Hassan Y. Aboul-Enein
Pharmaceutical and Medicinal Chemistry Department
Pharmaceutical and Drug Industries Research Division,
National Research Centre
Dokki, Cairo 12311, Egypt
Tel: +201003678948
+20103678948
+2023 3370931/33601877 Fax: +20233370931

E-mail: haboulenein@yahoo.com 
and enein@gawab.com
https://www.researchgate.net/profile/Hassan_Aboul-Enein
https://www.linkedin.com/in/hassan-aboul-enein-9535a838

 

Summary

Professor Hassan Y. Aboul-Enein received his first degree from Cairo University in 1964 and then went on to study in the United States, receiving a Ph.D. in Medicinal Chemistry from the University of Mississippi in 1971. In 2000, he was also awarded a DSc. from the University of Bucharest, Romania. He was an assistant professor at the University of Alabama in Birmingham and the University of Iowa before joining the pharmaceutical industry in the United States.
Professor Aboul-Enein has also occupied a number of posts outside the United States, including King Saud University and later at King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia. He was a visiting professor at the University of Sydney, the University of Nebraska, Ain Shams University, Universiti Sains Malaysia, Shandong University China, the University of Sharjah, University Teknologie Malaysia (UTM), University of Bechar,Bechar, Algeria and Mahatma Ghandi University, Kottayam, India.
Currently, Professor Aboul-Enein is an Emeritus Professor at the National Research Center in Cairo. He is a consultant for several academic institutions in Malaysia, China, the United States, Turkey, Algeria, and Australia. He is also in the WHO-UN Expert Advisory Panel on the International Pharmacopoeia and Pharmaceutical Preparations.
Moreover, Professor Aboul-Enein is on the editorial board of several peer reviewed journals. His research interests are in the areas of pharmaceutical and biomedical analysis and he has published, over the course of his long career, more than 1000 scientific papers on pharmaceutical and biomedical analysis, in addition to 8 books and numerous presentations at international scientific conferences. He holds a US Patent and has received various honors and awards



Experience


Education


UNIVERSITY OF MISSISSIPPI SCHOOL OF PHARMACY,MISSISSIPPI,USA

PhD, PHARMACEUTICAL CHEMISTRY

RESEARCH ACTIVITIES

- Pharmaceutical and biomedical analysis of drugs in bulk, pharmaceutical formulations and biological fluids.

- Chiral chromatography including molecular recognition in separation processes and method developments for analytical separations.

- Retention mechanisms in chromatography.

- Synthesis of biological active agents, specifically fluorinated medicinals.

-Construction and development of sensors and biosensors for the analysis of pharmaceuticals and biological active compounds with emphasis on chiral drugs.
Activities and Societies: a member of the World Health Organization (WHO) advisory panel in International Pharmacopoeia and Pharmaceutical Preparations, a Fellow of the Royal Society of Chemistry (UK)., Editorial Board member of several scientific journals.

Univerisity of Mississippi, University, Mississippi,USA



Research Experience

  • Jan 2013
    Jamia Millia Islamia - Central University · Department of Chemistry
    India · New Delhi
  • Jan 2012
    Xinxiang University
    China · Xinxiang
  • Jan 2011
    Menoufia University · Genetic Engineering and Biotechnology Research Institute(GEBRI)
    Egypt · Shibīn al Kawm
  • Jan 2011–Dec 2012
    West Pomeranian University of Technology, Szczecin
    Poland · Szczecin
  • Jan 2011
    Alzahra University · Department of Chemistry
    Iran · Tehrān
  • Jan 2011
    International University of Africa
    Sudan · Khartoum
  • Jan 2010
    Ain Shams University · Department of Chemistry
    Egypt · Cairo
  • Jan 2010
    Gazi University · Department of Chemistry
    Turkey · Ankara
  • Jan 2010–Dec 2012
    Institutul National De Cercetare – Dezvoltare Pentru Electrochimie Si Materie Condensata
    Romania · Timişoara
  • Jan 2009–Dec 2012
    Universiti Teknologi Malaysia · Department of Chemistry
    Malaysia · Johor Bahru
  • Jan 2009–Dec 2013
    University of Khartoum · Faculty of Science
    Sudan · Khartoum
  • Jan 2008–Dec 2009
    Shahid Beheshti University · Department of Phytochemistry
    Iran · Tehrān
  • Jan 2008–Dec 2012
    Jamia Millia Islamia · Department of Chemistry
    India · New Delhi
  • Jan 2008–Dec 2013
    Universiti Sains Malaysia · School of Chemical Sciences
    Malaysia · Nibong Tebal
  • Jan 2007
    Zagazig University · Department of Analytical Chemistry
    Egypt · Az Zaqāzīq
  • Jan 2007
    Razi University · Department of Chemistry
    Iran · Kermānshāh
  • Jan 2007
    Chemistry & Chemical Engineering Research Center of Iran
    Iran · Tehrān
  • Jan 2007
    Ataturk University · Department of Chemistry, Faculty of Science
    Turkey · Erzurum
  • Jan 2007
    Jiangsu Polytechnic university
    China · Changzhou
  • Jan 2006
    Gaziosmanpasa University · Department of Chemistry
    Turkey · Tokat
  • Jan 2006–Dec 2007
    University of Sharjah
    United Arab Emirates · Sharjah
  • Jan 2004
    Shanxi University
    China · Taiyuan
  • Jan 2004–Dec 2010
    Alexandria University · Department of Pharmaceutical Chemistry
    Egypt · Alexandria
  • Jan 2004
    Karl-Franzens-Universität Graz · Department of Pharmaceutical Technology
    Austria · Graz
  • Jan 2004–Dec 2005
    National Organization for Drug Control & Research
    Egypt · Cairo
  • Jan 2003–Dec 2005
    National Institute of Hydrology
    India · Roorkee
  • Jan 2003–Dec 2013
    Pomeranian Medical University in Szczecin
    Poland · Szczecin
  • Jan 2003
    Shandong University · Department of Chemistry
    China · Jinan
  • Jan 2003
    Eskişehir Osmangazi Üniversitesi
    Turkey · Eskişehir
  • Jan 2003–
    Dec 2004
    Ankara University · Division of Analytical Chemistry
    Turkey · Ankara
  • Jan 2003–Dec 2004
    University of Szczecin
    Poland · Szczecin
  • Jan 2002
    Uniwersytet Jagielloński · Medical College
    Poland · Kraków
  • Jan 2002–
    Dec 2013
    Universitatea din București · Faculty of Chemistry
    Romania · Bucharest
  • Jan 2002–
    Dec 2009
    Szczecin University of Technology
    Poland · Szczecin
  • Jan 2002–
    Dec 2004
    Jiangsu Institute of petrochemical Technology
    China · Changzhou
  • Jan 2001–
    Dec 2006
    Anadolu University · Faculty of Pharmacy
    Turkey · Eskişehir
  • Jan 1999–
    Dec 2006
    University of Pretoria · Department of Chemistry
    South Africa · Pretoria
  • Jan 1982–
    Dec 2011
    King Saud University · Department of Clinical Pharmacy
    Saudi Arabia · Riyadh
  • Jan 1975
    University of Alabama at Birmingham
    USA · Birmingham
  • Jan 1974
    Minneapolis Veterans Affairs Hospital
    USA · Minneapolis







https://www.flickr.com/photos/ibnusina_institute/sets/72157628088103266/with/6328349598/






Fluorinated HPLC Phases — Looking Beyond C18 for Reversed-Phase
Professor Hassan Y. Aboul-Enein
Pharmaceutical and Medicinal Chemistry Department, National Research Centre, Dokki, Cairo 12311, EGYPT
E-mail: haboulenein@yahoo.com and enein@gawab.com

Reversed-phase high performance liquid chromatography (HPLC) is one of the most utilized forms of chromatography. The C8 and C18 stationary phases are the most widely used for reversed-phase HPLC. However, analysts occasionally encounter difficult separations for which selectivity, ruggedness or reproducibility are not obtained easily using traditional C8 and C18 phases. These separations might require the use of novel or selective phases that interact with analytes in a manner different than C8 or C18 phases .
¢ These types of stationary phases separate compounds based upon selective stationary phase interactions such as steric recognition charge transfer or π–π interactions. One class of selective or novel phases that have been used for a variety of separations are fluorinated phases
¢ Fluorinated phases can provide different elution orders, leading to enhanced selectivity for difficult-to-separate compounds
¢ Fluorinated phases also offer the possibility to use simpler mobile phases and avoid using extreme pH conditions and complex mobile-phase preparations.
¢ Fluorinated packings also exhibit excellent selectivity for compounds having hydroxyl, nitro and other polar groups in large ring systems.
This presentation will present several types of fluorinated stationary phases and show several examples of how this extra selectivity has been used to achieve chromatographic separation for a broad range of applications.
Hassan-Y.-Aboul-Enein

 http://www.omicsonline.org/open-access/benzimidazole-derivatives-as-antidiabetic-agents-2161-0444-1000280.php?aid=56566



Gem Mathew,
I M.Sc. Chemistry students with Dr. Hassan Y. Aboul-Enein and wife. — with Divya Mathew and Bino George.


Principal Rev. Fr. N.V. Joseph Njarakkattil presents a memento to Dr. Hassan Y. Aboul-Enein.


 Seminar on 'Chiral Capillary Electrophoresis' by Dr. Hassan Y. Aboul-Enein (Professor of Pharmaceutical and Medicinal Chemistry,National Research Centre, Cairo, Egypt), at St. Thomas College, PalaNational Research Centre Dokki Cairo

Chiral Pollutants Distribution, Toxicity and Analysis by Chromatography and Capillary Electrophoresis - Imran Ali-Hassan Y Aboul-Enein

Download now for free
http://www.chem-books.com/analytical/item/226-chiral-pollutants-distribution-toxicity-and-analysis-by-chromatography-and-capillary-electrophoresis-imran-ali-hassan-y-aboul-enein.html
 
 
 


 
 
 
 
 
//////////
Posted by at 1 comment:
Labels: , , ,

Monday, 9 November 2015

Ranjana Smetacek, Director General at OPPI (Organisation of Pharmaceutical Producers of India)

Ranjana Smetacek

Ranjana Smetacek

Director General at OPPI (Organisation of Pharmaceutical Producers of India)
Mumbai, Maharashtra, India
On October 3, 2013, Ms Ranjana Smetacek has taken over as the director general of the Organization of Pharmaceutical Producers of India (OPPI).
OPPI, which was established in 1965, represents the research-driven pharmaceutical companies in India and remains committed to supporting the nation's healthcare objectives, collaborating with the Indian Government and other stakeholders to find sustainable solutions; solutions that balance the need for innovation with the necessity for more accessible medicines, within a robust IP environment. OPPI supports the Indian government's quest for more accessible and affordable medicines and welcomes a more comprehensive dialogue between private and government stakeholders.
LINKS
https://in.linkedin.com/pub/ranjana-smetacek/15/502/364

Ranjana Smetacek (@rsmetacek) | Twitter

https://twitter.com/rsmetacek
https://www.facebook.com/ranjana.smetacek

Summary

Ranjana Smetacek has worked in Communications and Public Relations for over 25 years. She has experience in several industries and on every continent.
After working for 10 years with a hotel, a pharma major and a PR agency, she spent a decade with Monsanto Company, the world's largest agri-business and a leader in crop biotechnology. Initially Ranjana was based out of Mumbai and Delhi, leading Government Affairs, Public Affairs and Industry Affairs for Monsanto in South Asia. India’s first biotech crop was approved during this time, largely due to a meticulously planned and PR-lead strategy. She was then picked for Monsanto's Asia Leadership Program and did several month-long stints in Australia and China.
After six years with Monsanto in India, Ranjana transferred to Monsanto's St. Louis headquarters as Director - Global Biotech Acceptance and also supported projects in Europe, Africa and South America. Later she was designated Director - International Communications and formed the link between Monsanto headquarters and its country Public Affairs teams around the world. She returned to India in 2009 to join Bharti Enterprises as Head - Brand & Corporate Communications. Later, she joined Fortis Healthcare to lead Marketing & Corporate Communications for the hospital network.
She has now returned to Mumbai to lead OPPI (Organisation of Pharmaceutical Producers of India) as Director General. This industry body represents the research-driven pharmaceutical companies in India and is focused on creating an environment conducive to innovation.
Specialties:
- Advocacy programs for outreach to diverse stakeholders
- Communications strategies that advance business objectives
- Experience across the globe that makes for the cultural sensitivity to be effective anywhere
- Training for effective communication, media preparedness, crisis containment

(L-R) Dr Shailesh Ayyangar, President, OPPI and Managing Director, India and Vice President, South Asia, Sanofi, Dr VK Subburaj, Secretary, Department of Pharmaceuticals and Ranjana Smetacek, Director General, OPPI

OPPI concludes 4th Healthcare Access Summit in Mumbai

http://www.financialexpress.com/article/pharma/market-pharma/organisation-of-pharmaceutical-producers-of-india-concludes-4th-healthcare-access-summit-in-mumbai/128135/

Experience

Director General

OPPI (Organisation of Pharmaceutical Producers of India
June 2013 – Present (2 years 6 months)Mumbai
I am Director General at OPPI (Organisation of Pharmaceutical Producers of India), an industry body that represents the research-driven pharmaceutical companies in India and is focused on creating an environment conducive to innovation.

Director - Marketing & Corporate Communications

Fortis Healthcare
February 2010 – July 2012 (2 years 6 months)New Delhi Area, India
I led Marketing and Corporate Communications for Fortis Healthcare for two and a half years, covering advertising, public relations and web-based communications. I helped address the marketing and communications challenges that face a rapidly growing organization - starting from a single hospital in Northern Indian in 2001 to a pan-Asian, nearly 70 hospital network in a decade.

Head - Group Corporate Communications & Brand

Bharti Enterprises Limited
March 2009 – January 2010 (11 months)New Delhi Area, India
I returned to India, after being selected in a global search by Bharti Enterprises. I reported to Sunil Mittal and was accountable for communications across all the group companies. I was ultimately responsible for the Bharti reputation and for profiling the top management. My focus was setting up world-class systems and processes for communications in this organization. It was my responsibility to take this function to the next level in a fast-growing organization, making it more strategic and building a solid foundation worthy of being benchmarked against the best.

Director - International Communications

2006 - 2009: Monsanto Company
March 2006 – March 2009 (3 years 1 month)Greater St. Louis Area
I transferred to Monsanto Company's headquarters in St. Louis and a position in the Global Biotech Acceptance team. Here I was responsible for building direct communication and a credible third party messenger program to communicate how crop biotechnology is delivering important benefits, especially for small farmers, rural villages, and nations in the developing world. In addition to numerous personal speaking opportunities around the globe I ensured the presence of other credible messengers at strategic global forums.
Director - International Communications: following a reorganization of the Commercial Acceptance function, I joined the Public Affairs team as the headquarters' person responsible for international press and communicating key Monsanto initiatives. Primary among these was Monsanto's Sustainable Yields Initiative and the Water Efficient Maize for Africa project. In this role, I worked with Public Affairs colleagues around the globe to ensure they were aligned with the communications vision in St. Louis and equipped with the materials and resources to implement it. I also saw it is as my task to be the 'global filter' at company headquarters, ensuring that management had a current picture of the PR realities in various geographies and that expectations around communications objectives were realistic.

Director - Government & Public Affairs

Monsanto Holdings Limited
November 1999 – March 2006 (6 years 5 months)Mumbai Area, India
I led the Commercial Acceptance function in South Asia, covering Government Affairs, Public Affairs and Industry Affairs in India and Pakistan. It was my responsibility to help shape perceptions around Ag Biotech and Monsanto, make the South Asia team a cohesive entity with a clear understanding of the issues and allegations we faced as well as the ability to handle them effectively. I supported the Asia Pacific Commercial Acceptance team, using my expertise and experience to add value in key countries like Australia and China, where I was invited to do several short-term assignments. My expertise lay in reacting speedily to sensitive issues, pre-empting negative situations, neutralizing damage through planned communications and proactively putting out positive messages. During the last year in this job, I also supported the Global Biotech Acceptance team in St. Louis and was its point person in Asia, leading a five member Asia Pacific team.
The deliverables were a positive environment for Biotech in the region and an understanding of Monsanto among key publics: primarily Media, Government, Scientific Community, Farmers, NGO's, Consumer Groups, Financial Community, Shareholders and Employees (measured through perception audits, general media tone, regulatory acceptance, and success in gaining endorsement/buy in from leaders among important publics; and gauged through the quality of communication tools).

Senior Manager - Corporate Communications

Ranbaxy Laboratories
October 1996 – November 1999 (3 years 2 months)New Delhi Area, India
I led the PR program and started and managed the company's website. I published periodic updates for Government, Industry and Diplomatic Missions around the world and handled statutory communication including the Annual Report and notices from the Company Secretary. I managed company events like the Annual General Meeting, Annual Day at various locations, scientific symposia and dinners hosted by the CEO. Internally, I managed timely communications in a rapidly growing organization spread across 40 countries – both the exchange of news from these countries and the writing and dissemination of communiqués from headquarters. I put out a bi-monthly newsletter designed for a diverse organization. Sadly, my final task at Ranbaxy was managing press around Dr. Parvinder Singh’s untimely demise and the succession issues arising from this.

Principal Consultant

Mudra Public Relations
August 1993 – November 1996 (3 years 4 months)New Delhi Area, India
I lead a client servicing team with a portfolio of 8-10 clients. Retainer accounts included Air India, Nestle, Samsung, Singapore Tourism Promotion Board, Bausch & Lomb, The Oberoi Hotel, JK Tyres, Sita World Travel, among others. Project clients were DCM Daewoo, Italian Trade Commission, Southern Pacific Hotel Corporation, Hindustan Motors, and Max Upjohn. During my last year with Mudra, I headed the Business Development Cell, pitching for new business in a (by then) very competitive environment.

Assistant Manager Public Relations

Hotel Holiday Inn
October 1988 – January 1992 (3 years 4 months)New Delhi Area, India
My function combined Media Relations, Guest Relations and Employee Relations. Besides interaction with the national and international press, I was required to co-ordinate image advertising with the Ad agency and produce printed collateral in co-ordination with the Graphics team. I also handled the employee orientation program, edited the in-house newsletter, created a monthly guest newsletter and wrote all in-room messages. Routine activity included monthly PR reports to the regional office in Hong Kong and analysis of PR strategy at competition hotels.

Education

University of Kumaon, Nainital

Master of Arts (MA), English
1983 – 1985

All Saints College

ISC, English
1963 – 1973

Michael Hauser, Ranjana Smetacek
Diane Herndon, Johnathan Yordy, Jill Kuehnert, Ranjana Smetacek








 
with srk - at the Airtel Delhi half marathon

////////
Posted by at No comments:
Labels: , ,
Subscribe to: Posts (Atom)